Orca Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.72M Buy
10,403
+55
+0.5% +$14.1K 1.62% 20
2026
Q2
$2.6M Buy
10,348
+49
+0.5% +$10.5K 1.56% 20
2026
Q1
$2.24M Sell
10,299
-17
-0.2% -$3.77K 1.59% 22
2025
Q4
$2.35M Buy
10,316
+68
+0.7% +$15.5K 1.68% 21
2025
Q3
$2.37M Buy
10,248
+23
+0.2% +$4.68K 1.8% 18
2025
Q2
$1.9M Sell
10,225
-254
-2% -$47.2K 1.6% 21
2025
Q1
$2.2M Buy
10,479
+32
+0.3% +$6.22K 1.96% 16
2024
Q4
$1.86M Buy
+10,447
New +$1.92M 1.67% 20

Other funds holding ABBV

Orca Wealth Management's ABBV Position: Q3 2026 in Review

Orca Wealth Management increased its AbbVie (ABBV) stake by 0.53% in Q3 2026, buying an estimated $14.1K and bringing the position to 10,403 shares worth $2.72M. The position accounts for 1.62% of the portfolio, ranked #20.

Orca Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Orca Wealth Management held 10,403 shares of AbbVie worth $2.72M as of Q3 2026.
  • Orca Wealth Management bought 55 AbbVie shares in Q3 2026, an estimated $14.1K.
  • AbbVie made up 1.62% of Orca Wealth Management's portfolio in Q3 2026, its #20 holding.
  • Orca Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Orca Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.